Mr. Tim NietersSenior Vice President of Strategic Portfolio at CPC ScientificSpeaker
Agenda Sessions
Case Study on the GMP Development and Manufacturing Process for DOTAGA-Labeled Urea-Based Peptide PSMA Inhibitor, DOTAGA-(I-y)fk(Sub-KuE)
, 7:45amView Session